Outcomes of Implantable Cardioverter-Defibrillator Use in Patients With Comorbidities
Explore this paper's citation graph
Summary
Patients with extensive comorbid medical illnesses may experience less benefit from primary prevention ICDs than those with less comorbidity; implantation should be carefully considered in sick patients.
- Type
- review
- Published
- 2014-10-08
- Cited by
- 95
- References
- 20
- Access
- Open access
- OpenAlex
- https://openalex.org/W31743073
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:3960025
Keywords
Medicine, Hazard ratio, Comorbidity, Internal medicine, Cardiology
References
- Prophylactic Defibrillator Implantation in Patients With Nonischemic Dilated Cardiomyopathy
- WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility
- The Longitudinal Study of Implantable Cardioverter Defibrillators: Methods and Clinical Characteristics of Patients Receiving Implantable Cardioverter Defibrillators for Primary Prevention in Contemporary Practice
- Cost-effectiveness of implantable cardioverter-defibrillators.
- A history of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study.
- Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy.
- Effect of cardiac and noncardiac conditions on survival after defibrillator implantation.
- Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection.
- The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial.
- Survival of Patients Receiving a Primary Prevention Implantable Cardioverter-Defibrillator in Clinical Practice vs Clinical Trials
- Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
- Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction.
- Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.
- Effect of Implantable Defibrillators on Arrhythmic Events and Mortality in the Multicenter Unsustained Tachycardia Trial
- Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention
- A New Equation to Estimate Glomerular Filtration Rate
- A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
- Improved Survival Associated with Prophylactic Implantable Defibrillators in Elderly Patients with Prior Myocardial Infarction and Depressed Ventricular Function: A MADIT-II Substudy
- Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.
- PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION
Cited by
- Multiple Comorbidities and Response to Cardiac Resynchronization Therapy: MADIT-CRT Long-Term Follow-Up
- Prediction of Nonarrhythmic Mortality in Primary Prevention Implantable Cardioverter-Defibrillator Patients With Ischemic and Nonischemic Cardiomyopathy.
- Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
- The Pilot European Survey of Atrial Fibrillation: how to look at heart failure through a keyhole
- A Shocking End to the Defibrillator as We Know It: Unmet Needs and the Case for a Stand‐Alone Device that Uses Pacing Only to Treat the Risk of Life‐Threatening Arrhythmias
- National Trends in the Utilization of Cardiac Resynchronization Therapy with or without Implantable-Cardioverter Defibrillator
- Mapping the Terrain of Competing Risk Following Primary Prevention Defibrillator Implantation.
- Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
- Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view
- Effect of Advancing Age and Multiple Chronic Conditions on Mortality in Patients with End-Stage Renal Disease after Implantable Cardioverter-Defibrillator Placement.
- Implications of Frailty in Elderly Patients With Electrophysiological Conditions.
- Usefulness of Atrial Fibrillation as a Marker for Adverse Cardiovascular Outcomes in Both Primary and Secondary Prevention in Patients With Implantable Cardioverter-Defibrillators.
- The ICD in Heart Failure - Time for a Rethink?
- Antibiotic Prophylaxis for Cesarean Delivery - When Broader Is Better.
- Mode of Death in Octogenarians Treated With Cardiac Resynchronization Therapy.
- Defibrillators: Selecting the Right Device for the Right Patient
- Effect of a Reminder Statement on Echocardiography Reports on Referrals for Implantable Cardioverter-Defibrillators for Primary Prevention.
- Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
- Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy.
- The impact of co‐morbidity burden on appropriate implantable cardioverter defibrillator therapy and all‐cause mortality: insight from Danish nationwide clinical registers
Related papers
- Death, mode of death, morbidity and requirement for rehospitalization during 2 years after coronary artery bypass grafting in relation to preoperative ejection fraction
- Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival
- Influence of comorbidity on the choice of treatment and survival of elderly patients with advanced non-small cell lung cancer
- Changes in Left Ventricular Ejection Fraction (LVEF) Predict Mortality in Heart Failure Patients With Reduced Ejection Fraction
- Prognostic implications of late gadolinium enhancement for re-worsening left ventricular ejection fraction in patients with dilated cardiomyopathy: a longitudinal study of left ventricular function
- Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice.
- Health Care Resource Utilization And Costs Associated With HIV-Positive Patients With Comorbidity Versus HIV-Negative Patients With Comorbidity
- A Family History of Sudden Death Should Not Be a Primary Indication for an Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy.
- Automatic implantable cardioverter defibrillator: when not to implant.